Suppr超能文献

荷瘤小鼠胃肠道细菌易位增加。

Increased translocation of bacteria from the gastrointestinal tracts of tumor-bearing mice.

作者信息

Penn R L, Maca R D, Berg R D

出版信息

Infect Immun. 1985 Mar;47(3):793-8. doi: 10.1128/iai.47.3.793-798.1985.

Abstract

Aerobic gram-negative bacilli and other indigenous gastrointestinal (GI) bacteria are important opportunistic pathogens in immunosuppressed cancer patients. These same bacteria frequently translocate from the GI tracts of mice immunosuppressed by single injections of certain anticancer drugs or by T-lymphocyte impairments. Since similar cellular and humoral immune deficiencies may be present in the tumor-bearing host, we sought to determine if progressive growth of a tumor alone would be sufficient to enhance the translocation of indigenous bacteria from the murine GI tract. Pathogen-free DBA/2 mice were injected intraperitoneally with 10(6) viable sarcoma 180 (S-180) cells or 0.5 ml of sterile buffer. Mesenteric lymph nodes, livers, spleens, and kidneys were tested for the presence of translocated aerobic GI bacteria on various days after tumor injection. Immunity was assessed by measuring footpad delayed-type hypersensitivity and serum hemagglutinins to sheep erythrocytes. Overall, translocated aerobic GI bacteria infected 33 of 92 S-180-bearing mice (36%) and only 9 of 99 control mice (9%) (P less than 10(-6)). Cumulatively, 50 of 460 sites (10.9%) in S-180-bearing mice were infected with translocated GI bacteria as opposed to only 9 of 485 sites (1.9%) in control animals (P less than 10(-7)). GI bacteria often translocated to infect more than one site in tumor-bearing mice, but not in controls. Aerobic gram-negative bacilli translocated 11 times in tumor-bearing mice, but only once in controls, even though the mean cecal population levels of these bacteria were relatively low (range, 4.33 to 5.28 log10 bacteria per g). The population levels of cecal aerobic bacteria were similar in S-180 and control mice throughout the period of observation. S-180 mice had significantly suppressed (P less than 0.04) delayed-type hypersensitivity and serum hemagglutinin responses when sensitized 4 or 8 days after S-180 injection. S-180 growth was associated with a neutrophilic leukocytosis and a slight drop in platelet counts; no bleeding was detected. Thus, the translocation of gram-negative bacilli and other indigenous aerobic bacteria from the GI tract to the mesenteric lymph nodes and other organs was increased in immunosuppressed S-180-bearing mice, and this increase was not caused by bacterial overgrowth in the intestines or by neutropenia.

摘要

需氧革兰氏阴性杆菌和其他肠道固有细菌是免疫抑制癌症患者重要的机会致病菌。这些细菌经常从小鼠肠道移位,这些小鼠通过单次注射某些抗癌药物或因T淋巴细胞损伤而免疫抑制。由于荷瘤宿主中可能存在类似的细胞和体液免疫缺陷,我们试图确定肿瘤的渐进性生长是否足以增强肠道固有细菌从小鼠胃肠道的移位。将无特定病原体的DBA/2小鼠腹腔注射10(6)个活的肉瘤180(S-180)细胞或0.5 ml无菌缓冲液。在肿瘤注射后的不同天数,检测肠系膜淋巴结、肝脏、脾脏和肾脏中是否存在移位的需氧肠道细菌。通过测量足垫迟发型超敏反应和对绵羊红细胞的血清血凝素评估免疫功能。总体而言,92只荷S-180小鼠中有33只(36%)感染了移位的需氧肠道细菌,而99只对照小鼠中只有9只(9%)感染(P小于10(-6))。累计而言,荷S-180小鼠460个部位中有50个(10.9%)被移位的肠道细菌感染,而对照动物485个部位中只有9个(1.9%)被感染(P小于10(-7))。肠道细菌经常移位至荷瘤小鼠的多个部位感染,但对照小鼠不会。需氧革兰氏阴性杆菌在荷瘤小鼠中移位11次,而对照小鼠中仅移位1次,尽管这些细菌的盲肠平均菌量相对较低(范围为每克4.33至5.28 log10细菌)。在整个观察期内,S-180小鼠和对照小鼠的盲肠需氧菌量相似。S-180小鼠在注射S-180后4天或8天致敏时,迟发型超敏反应和血清血凝素反应显著受抑(P小于0.04)。S-180生长与中性粒细胞增多和血小板计数略有下降有关;未检测到出血。因此,在免疫抑制的荷S-180小鼠中,革兰氏阴性杆菌和其他肠道需氧菌从小肠向肠系膜淋巴结和其他器官的移位增加,且这种增加不是由肠道细菌过度生长或中性粒细胞减少引起的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验